Survival benefit of allogeneic HSCT in CMML patients during the molecular stratification era. Ma R, Zhang J, Zhang MX, Li Y, et al. Cancer Lett 2026;649:218489.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma R, Zhang J, Zhang MX, Li Y, et al. Survival benefit of allogeneic HSCT in CMML patients during the molecular stratification era. Cancer Lett 2026;649:218489.
PMID: 41950987